Qualitative and Quantitative Differences in the Immune Response to Foot-and-Mouth Disease Virus Antigens and Synthetic Peptides

References

1. BACHRACH H. L., MOORE D. M., MCKERCHER P. D., POLATNICK J. 1975; Immune and antibody responses to an isolated capsid protein of foot and mouth disease virus. Journal of Immunology 115:1635–1641
   [Google Scholar]
2. BITTLE J. L., HOUGHTEN R. A., ALEXANDER J., SHINNICK T. M., SUTCLIFFE J. G., LERNER R. A., ROWLANDS D. J., BROWN F. 1982; Protection against foot and mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
   [Google Scholar]
3. BROWN F., CARTWRIGHT B. 1963; Purification of radioactive foot-and-mouth virus. Nature, London 199:1168–1170
   [Google Scholar]
4. BROWN F., NEWMAN L. F. E. 1963; In vitro measurement of the potency of inactivated foot-and-mouth disease virus vaccine. Journal of Hygiene 61:345–351
   [Google Scholar]
5. BURROUGHS J. N., ROWLANDS D. I., SANGAR D. V., TALBOT P., BROWN F. 1971; Further evidence for multiple proteins in the foot-and-mouth disease virus particle. Journal of General Virology 13:73–84
   [Google Scholar]
6. CARTWRIGHT B., CHAPMAN W. G., BROWN F. 1980; Serological and immunological relationships between the 146S and 12S particles of foot-and-mouth disease virus. Journal of General Virology 50:369–375
   [Google Scholar]
7. CARTWRIGHT B., MORRELL D. J., BROWN F. 1982; Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1. Journal of General Virology 63:375–381
   [Google Scholar]
8. EMINI E. A., JAMESON B. A., WIMMER E. 1983; Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature, London 304:699–703
   [Google Scholar]
9. FRANCIS M. J., BLACK L. 1983; Antibody response in pig nasal fluid and serum following foot and mouth disease infection or vaccination. Journal of Hygiene 91:329–334
   [Google Scholar]
10. FRANCIS M. J., FRY C M., ROWLANDS D. J., BROWN F., BITTLE J. L., HOUGHTEN R. A., LERNER R. A. 1985a Priming with peptides of foot-and-mouth disease virus. Vaccines 85203–210 Edited by Lerner R. A., Chanock R. M., Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
11. FRANCIS M. J., FRY C. M., ROWLANDS D. J., BROWN F., BITTLE J. L., HOUGHTEN R. A., LERNER R. A. 1985b; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
    [Google Scholar]
12. KURZ C, FORSS S., KUPPER N., STROHMAIER K., SCHALLER N. 1981; Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus. Nucleic Acids Research 9:1919–1931
    [Google Scholar]
13. LAPORTE J., GROSCLAUDE J., WANTYGHEM J., BERNARD S., ROUZE P. 1973; Neutralization en culture cellulaire du pouvoir infectieux du virus de la fievre aphteuse par des serums provenant de porcs immunises a l’aide d’une protéine virale purifiée. Comptes rendus hebdomadaires des séances de l’Académie des sciences D 276:3399–3401
    [Google Scholar]
14. LIU F.-T., ZINNECKER M., HAMAOKA T., KATZ D. H. 1979; New procedures for preparation and isolation of conjugates of proteins and synthetic co-polymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry 18:690–697
    [Google Scholar]
15. MELOEN R. H., BARTELING S. J. 1986a; Epitope mapping of the outer structural protein VP1 of three different serotypes of foot-and-mouth disease virus. Virology 149:55–63
    [Google Scholar]
16. MELOEN R. H., BARTELING S. J. 1986b; An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type 0 induces neutralizing activity but poor protection. Journal of General Virology 67:289–294
    [Google Scholar]
17. MELOEN R. H., ROWLANDS D. J., BROWN F. 1979; Comparison of the antibodies elicited by the individual structural polypeptides of foot-and-mouth disease and polio viruses. Journal of General Virology 45:761–763
    [Google Scholar]
18. OULDRIDGE E. J., CLARKE B. E., BARNETT P. V., BROWN A., PARRY N. R., BOLWELL C, ROWLANDS D. J., BROWN F. 1986 Designing foot and mouth disease virus peptide vaccines with broad serological cross reactivity. Foot and Mouth Disease. 17th Conference223–228 Paris: Office International des Épizooties;
    [Google Scholar]
19. PFaFF E., MUSSGAY M., BOHM N. O., SCHULZ G. E., SCHALLER H. 1982; Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO Journal 1:869–874
    [Google Scholar]
20. STROHMAIER K., FRANZE R., ADAM K.-H. 1982; Location and characterization of the antigenic portion of FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
21. TALBOT P., ROWLANDS D. J., BURROUGHS J. V., SANGAR D. V., BROWN F. 1973; Evidence for a group protein in foot-and-mouth disease virus particles. Journal of General Virology 19:369–380
    [Google Scholar]
22. VOLLER A., BIDWELL D. E. 1976; Enzyme immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccinations. British Journal of Experimental Pathology 57:243–247
    [Google Scholar]
23. WILD T. F., BURROUGHS J. N., BROWN F. 1969; Surface structure of foot-and-mouth disease virus. Journal of General Virology 4:313–320
    [Google Scholar]